Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Bioinventum AB
AB
Active
Org 5593174963
Bösmöllevägen 16
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2021
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
+38% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -8K
+38% vs 2023
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -8K
+38%
Net profit
SEK -8K
+38%
Total assets
SEK 25K
-24%
Equity
SEK 25K
-22%
Employees
0
—
Company information
Legal name
Bioinventum AB
Org number
5593174963
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14 maj 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom life science
Contact
Address
Bösmöllevägen 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Kävlinge
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
184
0
0
0
Staff expenses
—
—
—
—
EBITDA
35
−33
−13
−8
Depreciation & amort.
−0
−0
−0
−0
EBIT
35
−33
−13
−8
Net financials
—
—
—
—
Profit before tax
35
−33
−13
−8
Tax
−7
−0
−0
−0
Net profit
28
−33
−13
−8
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
117
27
33
25
Equity
53
20
32
25
Long-term debt
0
0
0
0
Short-term debt
64
7
0
0
Total debt
64
7
—
—
Financial ratios
5-year trend
EBITDA margin
-800000.0%
This company
15.8%
Market median
-5063391% vs market
2021
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2021
2024
Return on equity
-32.0%
This company
18.4%
Market median
-274% vs market
2021
2024
Net profit margin
-800000.0%
This company
8.1%
Market median
-9876643% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
PO
Peter Otto Falck
Board of Directors
2022
—
—
VI
Virginia Iovana Falck
Deputy Board Member
2022
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Bioinventum AB also hold positions in
0
other companies.
Person
Role here
Other companies
Peter Otto Falck
Board of Directors
0 companies
Virginia Iovana Falck
Deputy Board Member
0 companies